-
Mashup Score: 2More ARNI Insights Fortify Role in ‘Below Normal’ LVEF: PARAGLIDE-HF - 10 month(s) ago
The trial, as well as pooled data with PARAGON-HF, should solidify a role for sacubitril/valsartan after worsening HF events.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 13
AbstractBackground and aims. The PARAGLIDE-HF trial demonstrated reductions in natriuretic peptides with sacubitril/valsartan compared with valsartan in patient
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
🔥 Another proof of benefit of #ARNI in #HFmrEF & #HFpEF especially after a recent #HF 🏥 ❤️🔥 #ARNI is more effective in ⬇️ Total #HF events + #CV ☠️ 🍀 #ARNI is safer (safer!) than #ARB about #renal events & function & #hyperk+ https://t.co/T7oWyKbHOT @mvaduganathan @gcfmd https://t.co/Y9yveFF9l7 https://t.co/CVohy6ptnz
-
-
Mashup Score: 9Simultaneous or Rapid Sequence Initiation of Quadruple Medical Therapy for Heart Failure - 11 month(s) ago
This Viewpoint advocates for expanded use of quadruple therapy in patients with heart failure with reduced ejection fraction.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Acute asymptomatic hyponatraemia following inpatient initiation of angiotensin receptor–neprilysin inhibitor: a case report - 1 year(s) ago
AbstractBackground. Utilization of sacubitril/valsartan is increasing as a component of guideline-directed medical therapy in patients with heart failure with r
Source: OUP AcademicCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0ISHLT: The International Society for Heart & Lung Transplantation - March 2023 - AHFTX - 1 year(s) ago
This webinar will discuss a variety of topics in the management of an advanced heart failure patient. The use of contemporary therapies such as ARNI, SGLTI, novel anticoagulants, amiodarone, ablation, and inotropes in a heart transplant or LVAD candidate, and the potential implications on transplantation and durable LVAD outcomes. Attendees will gain practical insights from expert speakers on the…
Source: ishlt.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0ISHLT: The International Society for Heart & Lung Transplantation - March 2023 - AHFTX - 1 year(s) ago
This webinar will discuss a variety of topics in the management of an advanced heart failure patient. The use of contemporary therapies such as ARNI, SGLTI, novel anticoagulants, amiodarone, ablation, and inotropes in a heart transplant or LVAD candidate, and the potential implications on transplantation and durable LVAD outcomes. Attendees will gain practical insights from expert speakers on the…
Source: ishlt.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Quality of Care and Outcomes Among Patients Hospitalized for Heart Failure in Rural vs Urban US Hospitals - 1 year(s) ago
This cohort study assesses quality of care and clinical outcomes for US patients hospitalized for heart failure at rural vs urban hospitals in the Get With The Guidelines–Heart Failure registry.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
In this large contemporary cohort of US patients hospitalized for HF, patients at rural hospitals were less likely to receive multiple elements of guideline-directed HF care, such as #CRT, #ACEI/#ARB, and #ARNI therapies https://t.co/ncIVNV8q5r #HeartFailure @JAMACardio… https://t.co/JWtKHGtCv3 https://t.co/kEzYM6JqMx
-
-
Mashup Score: 2Medication-Attributable Adverse Events in Heart Failure Trials - 1 year(s) ago
Initiation and up-titration of guideline-directed medical therapies (GDMTs) for heart failure with reduced ejection fraction (HFrEF) remains suboptima…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Comparative Risk of Angioedema With Sacubitril-Valsartan vs Renin-Angiotensin-Aldosterone Inhibitors - 1 year(s) ago
Data on angioedema risk among sacubitril-valsartan (SV) users in real-world settings are limited.We sought to evaluate the risk of angioedema among SV…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
Amid debate over HF drug initiation and titration: a new study supports starting with sacubitril/valsartan, not switching to it.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet
More #ARNI Insights Fortify Role in ‘Below Normal’ #LVEF: #PARAGLIDE-HF The trial, as well as pooled data with #PARAGON-HF, should solidify a role for sacubitril/valsartan after worsening HF events @TCTMD @ShelleyWood2 @mmamas1973 #HeartFailure2023 https://t.co/CcMUGMzrdt